Cardiovascular System Practice Questions

Q: Aortic valve closure corresponds to the beginning of which phase of the cardiac cycle?

Isovolumetric relaxation. ***Isovolumetric relaxation*** - **Aortic valve closure** marks the end of **ventricular ejection** and the beginning of **isovolumetric relaxation** as both the aortic and mitral valves are closed, and ventricular pressure drops without a change in volume. - This phase is vital for the heart to relax and prepare for filling, corresponding to the **second heart sound (S2)**. *Systole* - **Systole** refers to the **contraction phase** of the heart, encompassing both isovolumetric contraction and ventricular ejection. - Aortic valve closure signifies the end of the **ejection phase** of systole, not its beginning. *Parasystole* - **Parasystole** is an **arrhythmia** where an ectopic pacemaker competes with the normal sinus rhythm, leading to independent atrial or ventricular contractions. - It is a **pathological condition** and not a normal phase of the cardiac cycle. *Isovolumetric contraction* - **Isovolumetric contraction** occurs after the **mitral valve closes** and before the aortic valve opens, causing pressure to build in the ventricle. - This phase precedes **ventricular ejection** and is initiated by mitral valve closure, not aortic valve closure.

Q: Which of the following structures contains baroreceptors that detect changes in blood pressure?

Carotid sinus. ***Carotid sinus*** - The **carotid sinus** is a dilation at the bifurcation of the common carotid artery, containing **baroreceptors** sensitive to changes in blood pressure [1]. - These baroreceptors are **mechanoreceptors** that respond to the stretching of the vessel wall due to increased arterial pressure, sending signals to the brainstem to regulate blood pressure. *Carotid body* - The **carotid body** is a chemoreceptor that primarily detects changes in **blood oxygen, carbon dioxide, and pH** levels, not blood pressure [2]. - It plays a crucial role in regulating **respiration** in response to hypoxemia. *Aortic body* - The **aortic body** is a **chemoreceptor** located near the aortic arch that primarily monitors **blood oxygen, carbon dioxide, and pH levels**. - Note: While the aortic body itself is a chemoreceptor, the **aortic arch** (a different structure) does contain baroreceptors [1]. However, this option specifically refers to the aortic body, which is not a baroreceptor. - The aortic body contributes to the regulation of **respiration** in response to hypoxemia, not directly blood pressure. *None of the options* - This option is incorrect because the **carotid sinus** is a well-known site for baroreceptors involved in blood pressure regulation.

Q: Aortic valve closure occurs in which part of cardiac cycle?

Beginning of isovolumetric relaxation. ***Beginning of isovolumetric relaxation*** - Aortic valve closure marks the end of **ventricular systole** and the start of **isovolumetric relaxation**, as blood ceases to be ejected and the ventricle begins to relax while remaining closed. - This event corresponds to the **second heart sound (S2)** and signifies the beginning of a period where ventricular volume remains constant, but pressure drops. *Beginning of isovolumetric contraction* - This phase begins with the closure of the **mitral and tricuspid valves** (first heart sound, S1), as ventricular pressure rises but volume remains constant before ejection. - The aortic valve is still closed at this point, as ventricular pressure is not yet high enough to open it. *Beginning of ventricular ejection* - This phase begins when the **aortic valve opens** as ventricular pressure exceeds aortic pressure, allowing blood to be ejected from the left ventricle. - Aortic valve closure occurs *after* ejection, not at its beginning. *During rapid ventricular filling* - Rapid ventricular filling occurs when the **mitral valve opens** (following isovolumetric relaxation), allowing blood to flow from the atria into the ventricles. - During this phase, the aortic valve is closed, but its closure happened earlier, at the beginning of isovolumetric relaxation.

Q: Cerebral blood flow is regulated by all, EXCEPT:

Potassium ions. ***Potassium ions*** - While potassium ions play a crucial role in neuronal excitability and membrane potential, they are **not a primary direct regulator** of cerebral blood flow (CBF) in the same way as other factors listed. - Changes in extracellular potassium can affect vascular smooth muscle, but their direct impact on CBF auto-regulation is less pronounced compared to metabolic or pressure-related factors. *Intracranial pressure* - **Increased intracranial pressure (ICP)** can significantly decrease cerebral blood flow due to the **Monro-Kellie doctrine**, which states that an increase in ICP reduces the cerebral perfusion pressure (CPP). - A sustained and significant elevation in ICP can lead to **cerebral ischemia** as it opposes the arterial pressure driving blood into the brain. *Arterial PCO2* - **Arterial PCO2** is a potent regulator of cerebral blood flow, with **hypercapnia (high PCO2)** causing **vasodilation** and increased CBF. - Conversely, **hypocapnia (low PCO2)** leads to **vasoconstriction** and decreased CBF, which is a key mechanism in the management of cerebral edema. *Cerebral metabolic rate* - **Cerebral metabolic rate (CMR)** is directly coupled to cerebral blood flow, meaning that regions of the brain with higher metabolic activity receive increased blood flow. - This **neurovascular coupling** ensures adequate supply of oxygen and nutrients to meet the brain's metabolic demands.

Q: Inotropic effect of thyroid hormone is by ?

Enhancement of Catecholamines. ***Enhancement of Catecholamines*** - Thyroid hormones **potentiate the effects of catecholamines** (like adrenaline and noradrenaline) on the heart, leading to increased heart rate and contractility, which is an **inotropic effect**. - This occurs by increasing the number and sensitivity of **beta-adrenergic receptors** on cardiac muscle cells. *Membrane receptors* - While thyroid hormones do have some rapid, non-genomic effects that may involve **membrane receptors**, their primary and well-established inotropic effect is mediated indirectly through catecholamine sensitivity. - The classic action of thyroid hormones is via intracellular receptors that modulate gene expression, not direct membrane receptor signaling for inotropic effects. *cAMP* - **cAMP** is a common second messenger for many hormones, particularly those acting via G protein-coupled receptors. - While catecholamines themselves act through cAMP to exert their cardiac effects, thyroid hormones *enhance the action* of catecholamines rather than directly using cAMP as their primary inotropic mechanism. *cGMP* - **cGMP** is a second messenger often associated with nitric oxide signaling and vasodilation, contributing to cGMP-dependent protein kinases. - It is not the primary mediator for the *positive inotropic effect* of thyroid hormones on the heart.

Q: What is the primary role of ion channels in the vascular endothelium?

Potassium ion regulation in endothelial cells. ***Potassium ion regulation in endothelial cells*** - **Potassium channels**, particularly **KCa3.1 (IKCa)** and **KCa2.3 (SKCa)**, are the **primary ion channels** in vascular endothelium - They maintain the **endothelial membrane potential** at hyperpolarized levels (around -40 to -70 mV) - This hyperpolarization **enhances eNOS activity**, promoting **nitric oxide (NO) release** and **vasodilation** - Potassium channels are thus critical regulators of **vascular tone** and **endothelial-dependent relaxation** *Calcium ion regulation in endothelial cells* - While **calcium ions** are essential for endothelial signaling and triggering NO release, calcium channels serve more as **secondary messengers** rather than primary regulators - **Calcium influx** (via TRP channels, store-operated channels) typically **activates** the potassium channels, which then provide the primary regulatory control - Calcium acts as a **trigger**, while potassium channels provide **sustained regulation** of membrane potential *Chloride ion regulation in endothelial cells* - **Chloride channels** are involved in **cell volume regulation** and may modulate membrane potential - Their role in endothelial cells is **less well-characterized** and not considered the primary mechanism for regulating vascular tone - They play more supportive rather than primary regulatory roles in endothelial function *Sodium ion regulation in endothelial cells* - **Sodium channels** are crucial in **excitable cells** (neurons, muscle) for action potential generation - In **non-excitable endothelial cells**, sodium transport is important for cellular homeostasis but does not constitute the **primary ion channel regulatory mechanism** for vascular function - Endothelial cells rely primarily on potassium channels for membrane potential regulation rather than sodium channels

Q: During the sympathetic fight-or-flight response, what is the primary cardiovascular effect of epinephrine and norepinephrine on skeletal muscle vasculature?

Increased blood flow to muscles. ***Increased blood flow to muscles*** - **Epinephrine** and **norepinephrine** cause **vasodilation** in skeletal muscle arterioles, shunting blood toward tissues critical for immediate physical action. - This response ensures that muscles have adequate **oxygen** and **nutrients** to support intense activity, enabling a quick escape or confrontation. *Increased blood flow to the skin* - During fight-or-flight, the body prioritizes essential organs, causing **vasoconstriction** in the skin to redirect blood flow away from non-essential areas. - This redirection helps to conserve blood and reduce potential blood loss from surface injuries. *Bronchoconstriction* - **Epinephrine** and **norepinephrine** actually cause **bronchodilation**, leading to the relaxation of airway smooth muscles. - This effect increases the diameter of the airways, allowing more air to enter and exit the lungs, thereby enhancing **oxygen intake** and carbon dioxide expulsion. *Decreased heart rate* - The primary effect of **epinephrine** and **norepinephrine** is to **increase heart rate** and myocardial contractility. - This cardiac acceleration enhances **cardiac output**, ensuring rapid and efficient delivery of oxygenated blood throughout the body to meet the demands of stress.

Q: In an ECG the cardiac event corresponding to the ST segment is:

Ventricular repolarisation. ***Ventricular repolarisation*** - The **ST segment** represents the **early phase of ventricular repolarization**, corresponding to the **plateau phase (Phase 2)** of the ventricular action potential. - During this phase, the ventricles are completely depolarized and calcium influx balances potassium efflux, creating an isoelectric (flat) segment on the ECG. - The ST segment extends from the **end of the QRS complex (J point)** to the **beginning of the T wave**, after which rapid repolarization occurs. - Together, the **ST segment and T wave** represent the complete process of ventricular repolarization. *Atrial depolarisation* - **Atrial depolarization** is represented by the **P wave** on the ECG, not the ST segment. - This occurs first in the cardiac cycle, triggering atrial contraction and filling of the ventricles. *Ventricular depolarisation* - **Ventricular depolarization** is represented by the **QRS complex**, which immediately **precedes** the ST segment. - This event triggers ventricular contraction (systole) and occurs before the plateau phase. *Atrial repolarisation* - **Atrial repolarization** occurs during the QRS complex and is **obscured** by the much larger electrical signal from ventricular depolarization. - It is not visible as a separate deflection on the standard ECG.

Q: Which of the following factors is most commonly targeted therapeutically for blood pressure control?

Peripheral resistance. ***Peripheral resistance*** - **Peripheral resistance** is primarily determined by the **arteriolar tone**, which can be effectively modulated by various antihypertensive medications. - Medications like **ACE inhibitors**, **ARBs**, **calcium channel blockers**, and **diuretics** all influence peripheral resistance to lower blood pressure. *Heart rate* - While heart rate contributes to **cardiac output** and thus blood pressure, it is not the most common primary target for hypertension management. - **Beta-blockers** reduce heart rate, but they are often used for specific indications beyond essential hypertension, such as angina or post-MI. *Cardiac output* - **Cardiac output** is a product of **heart rate** and **stroke volume**, and while it directly impacts blood pressure, directly targeting cardiac output as a whole is less common than modulating its individual components or peripheral resistance. - Many antihypertensive drugs reduce cardiac output as a secondary effect of reducing blood volume or heart rate, but directly reducing cardiac output is not the primary mechanism for the most common medications. *Stroke volume* - **Stroke volume** is influenced by **preload**, **afterload**, and **contractility**, and while it impacts cardiac output, it is generally less accessible for direct pharmacological manipulation in hypertension management compared to peripheral resistance. - **Diuretics** can indirectly reduce stroke volume by decreasing preload, but this is often considered a mechanism related to volume status rather than a direct myocardial effect.

Question 1

Aortic valve closure corresponds to the beginning of which phase of the cardiac cycle?

Accepted Answer

Isovolumetric relaxation

Answer

Systole

Answer

Parasystole

Answer

Isovolumetric contraction

Question 2

Which of the following structures contains baroreceptors that detect changes in blood pressure?

Accepted Answer

Carotid sinus

Answer

Carotid body

Answer

Aortic body

Answer

None of the options

Question 3

Aortic valve closure occurs in which part of cardiac cycle?

Accepted Answer

Beginning of isovolumetric relaxation

Answer

Beginning of isovolumetric contraction

Answer

During rapid ventricular filling

Answer

Beginning of ventricular ejection

Question 4

What does the ST Segment of an ECG correspond to?

Accepted Answer

Plateau phase between ventricular depolarization and repolarization

Answer

Ventricular depolarization

Answer

Atrial depolarization

Answer

AV Conduction

Question 5

Cerebral blood flow is regulated by all, EXCEPT:

Accepted Answer

Potassium ions

Answer

Intracranial pressure

Answer

Cerebral metabolic rate

Answer

Arterial PCO2

Question 6

Inotropic effect of thyroid hormone is by ?

Accepted Answer

Enhancement of Catecholamines

Answer

Membrane receptors

Answer

cAMP

Answer

cGMP

Question 7

What is the primary role of ion channels in the vascular endothelium?

Accepted Answer

Potassium ion regulation in endothelial cells

Answer

Chloride ion regulation in endothelial cells

Answer

Sodium ion regulation in endothelial cells

Answer

Calcium ion regulation in endothelial cells

Question 8

During the sympathetic fight-or-flight response, what is the primary cardiovascular effect of epinephrine and norepinephrine on skeletal muscle vasculature?

Accepted Answer

Increased blood flow to muscles

Answer

Increased blood flow to the skin

Answer

Bronchoconstriction

Answer

Decreased heart rate

Question 9

In an ECG the cardiac event corresponding to the ST segment is:

Accepted Answer

Ventricular repolarisation

Answer

Atrial depolarisation

Answer

Ventricular depolarisation

Answer

Atrial repolarisation

Question 10

Which of the following factors is most commonly targeted therapeutically for blood pressure control?

Accepted Answer

Peripheral resistance

Answer

Heart rate

Answer

Cardiac output

Answer

Stroke volume

Cardiovascular System — MCQs

Cardiovascular System — MCQs

On this page

Practice by Chapter

Want unlimited practice?